Novo Nordisk and Eli Lilly shares both fall after Novo’s price-cut plan for Ozempic and Wegovy


Shares of Novo Nordisk and rival Eli Lilly fell on Tuesday after a report said price cuts are coming for popular weight-loss drugs.

You May Also Like

Copper is the metal of the moment. What ETF investors need to know before chasing the commodity rally.

In this edition, we look at some of the copper-related ETFs that…

Some of the most popular trades of 2024 are coming undone after reaching ‘stupid’ levels

The selloff in U.S. semiconductor and megacap stocks has sucked up most…

Republican presidential rivals meet for Alabama debate — minus Donald Trump

Nikki Haley and Ron DeSantis jockeyed to be the Republican party’s alternative…

Here’s a key Social Security issue that Elon Musk’s DOGE task force could tackle — and it’s not fraud

Overpayments can be both costly to the government and to the beneficiaries…